Obesity Science, Research Gaps and Opportunities in the New Era of Obesity Medicines

The Endocrine Society requests your assistance in the development of its next Scientific Statement. Obesity Science, Research Gaps and Opportunities in the New Era of Obesity Medicines: An Endocrine Society Scientific Statement is available for Society member comment. Your comments will be reviewed by the authors and will be considered for inclusion in the final document. This comment period will be deactivated at 5:00 PM ET on Wednesday, April 8.

This statement, developed by a writing group led by Daniel J. Drucker, MD, and Ania M. Jastreboff, MD, PhD, has already undergone several stages of a rigorous review process. Scientific Statements are drafted by a group of content experts who draw on extensive knowledge of the scientific literature and personal expertise to craft authoritative reviews and recommendations for the field. This statement has undergone internal review by the Scientific Statement Subcommittee, the Research Affairs Core Committee, and expert external reviewers prior to the member comment period. To protect the Society's copyright and prevent multiple drafts from being circulated, please do not circulate this draft statement. At this time, we are seeking comments from Society members only.

Thank you in advance for taking the time to review and comment on this Statement. Please feel free to contact Joe Laakso at [email protected] if you have any questions.